Effect of oxyethylene moieties in hydrogenated castor oil on the pharmacokinetics of menatetrenone incorporated in O/W lipid emulsions prepared with hydrogenated castor oil and soybean oil in rats

Journal of Drug Targeting

Volumn 11, Issue 1, 2003, Pages 37-43

  Ueda, Kumiko ^a   Yamazaki, Yuka ^a   Noto, Hiromi ^a   Teshima, Yasuko ^a   Yamashita, Chiharu ^a   Sakaeda, Toshiyuki ^b   Iwakawa, Seigo ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

Hydrogenated castor oil; Lipid emulsions; Menatetrenone; Oxyethylene

Indexed keywords

HYDROGENATED CASTOR OIL; LIPID EMULSION; MENATETRENONE; PHOSPHOLIPID; POLYOXYETHYLENE DERIVATIVE; SOYBEAN OIL; TRIACYLGLYCEROL; WATER OIL CREAM;

ANIMAL EXPERIMENT; ARTICLE; BLOOD CELL; CIRCULATION TIME; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG LIVER LEVEL; DRUG RELEASE; DRUG UPTAKE; EGG YOLK; IN VITRO STUDY; MALE; NONHUMAN; PARTICLE SIZE; PLASMA HALF LIFE; PRIORITY JOURNAL; RAT;

ANIMALS; CASTOR OIL; CHEMISTRY, PHARMACEUTICAL; EMULSIONS; HYDROGENATION; LIPIDS; MALE; RATS; RATS, WISTAR; SOYBEAN OIL; VITAMIN K 2; WATER;

EID: 0037732580     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1061186031000086081     Document Type: Article

References (20)

1. Allen, T.M., Hansen, C., Martin, F., Redemann, C. and Yau-Young, A. (1991) "Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo", Biochim. Biophys. Acta 1066, 29-36.
2. Davis, S.S. (1997) "Biomedical applications of nanotechnology-implications for drug targeting and gene therapy", Trends Biotechnol. 15, 217-224.
3. Dunn, S.E., Brindley, A., Davis, S.S., Davies, M.C. and Illum, L. (1994) "Polystylene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution", Pharm. Res. 11, 1016-1022.
4. Illum, L., Davis, S.S., Müller, R.H., Mak, E. and West, P. (1987) "The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a blockcopolymer - poloxamine 908", Life Sci. 40, 367-374.
5. Klibanov, A.L., Maruyama, K., Torchilin, V.P. and Huang, L. (1990) "Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes", FEBS Lett. 268, 235-237.
6. Kurihara, A., Shibayama, Y., Yasuno, A., Ikeda, M. and Hisaoka, M. (1996) "Lipid emulsions of palmitoylrhizoxin: effects of particle size on blood dispositions of emulsion lipid and incorporated compound in rats", Biopharm. Drug Dispos. 17, 343-353.
7. Liu, F. and Liu, D. (1995) "Long-circulating emulsions (oil-in-water) as carriers for lipophilic drugs", Pharm. Res. 12, 1060-1064.
8. Lundberg, B.B., Mortimer, B.-C. and Redgrave, T.G. (1996) "Submicron lipid emulsions containing amphipathic polyethylene glycol for use as drug-carriers with prolonged circulation time", Int. J. Pharm. 134, 119-127.
9. Moghimi, S.M., Muir, I.S., Illum, L., Davis, S.S. and Kolb-Bachofen, V. (1993) "Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum", Biochim. Biophys. Acta 1179, 157-165.
10. Moghimi, S.M., Hunter, A.C. and Murray, J.C. (2001) "Long-circulating and target-specific nanoparticles: theory to practice", Pharmacol. Rev. 53, 283-318.
11. 1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo", FEBS Lett. 284, 263-266.
12. Papahadjopoulos, D., Allen, T.M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S.K., Lee, K.-D., Woodle, M.C., Lasic, D.D., Redemann, C. and Martin, F.J. (1991) "Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy", Proc. Natl Acad. Sci. USA 88, 11460-11464.
13. Sakaeda, T. and Hirano, K. (1995) "O/W lipid emulsions for parenteral drug delivery. II. Effect of composition on pharmacokinetics of incorporated drug", J. Drug Target. 3, 221-230.
14. Sakaeda, T. and Hirano, K. (1998a) "O/W lipid emulsions for parenteral drug delivery. III. Lipophilicity necessary for incorporation in oil particles even after intravenous injection", J. Drug Target. 6, 119-127.
15. Sakaeda, T. and Hirano, K. (1998b) "Effect of composition on biological fate of oil particles after intravenous injection of O/W lipid emulsions", J. Drug Target. 6, 273-284.
16. Stolnik, S., Daudali, B., Arien, A., Whetstone, J., Heald, C.R., Garnett, M.C., Davis, S.S. and Illum, L. (2001) "The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers", Biochim. Biophys. Acta 1514, 261-279.
17. Takino, T., Konishi, K., Takakura, Y. and Hashida, M. (1994) "Long circulating emulsion carrier systems for highly lipophilic drugs", Biol. Pharm. Bull. 17, 121-125.
18. Ueda, K., Ishida, M., Inoue, T., Fujimoto, M., Kawahara, Y., Sakaeda, T. and Iwakawa, S. (2001) "Effect of injection volume on the pharmacokinetics of oil particles and incorporated menatetrenone after intravenous injection as O/W lipid emulsions in rats", J. Drug Target. 9, 353-360.
19. Ueda, K., Fujimoto, M., Noto, H., Kawaguchi, Y., Sakaeda, T. and Iwakawa, S. (2002) "Effect of oxyethylene moiety in polyoxyethylene sorbitan esters on the pharmacokinetics of menatetrenone incorporated in O/W lipid emulsions prepared with polyoxyethylene sorbitan esters and soybean oil in rats", J. Pharm. Pharmacol. 54, 1357-1363.
20. Yuda, T., Maruyama, K. and Iwatsuru, M. (1996) "Prolongation of liposome circulation time by various derivatives of polyethyleneglycols", Biol. Pharm. Bull. 19, 1347-1351.